Peptide-Conjugated Silver Nanoparticles for the Colorimetric Detection of the Oncoprotein Mdm2 in Human Serum

Chempluschem. 2022 Apr;87(4):e202100450. doi: 10.1002/cplu.202100450. Epub 2022 Jan 19.

Abstract

The development of efficient, reliable, and easy-to-use biosensors allowing early cancer diagnosis is of paramount importance for patients. Herein, we report a biosensor based on silver nanoparticles functionalized by peptide aptamers for the detection of a cancer biomarker, i. e. the Mdm2 protein. Silver nanoparticles (AgNPs) were produced and stabilized with a thin PEGylated-calix[4]arene layer that allows (i) the steric stabilization of the AgNPs and (ii) the covalent conjugation of the peptide aptamers via the formation of an amide bond. These peptide-conjugated AgNPs were then used to detect Mdm2 via a dual trapping strategy that was previously reported with gold nanoparticles (AuNPs). Our results showed that replacing AuNPs by AgNPs improves the detection limit by nearly one order of magnitude, down to 5 nM, while the high selectivity of the system and the stability of the particles provided by the calixarene coating allow the detection of Mdm2 in human serum.

Keywords: calixarenes; colorimetric detection; oncoproteins; peptide aptamers; silver nanoparticles.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Colorimetry / methods
  • Gold* / chemistry
  • Humans
  • Metal Nanoparticles* / chemistry
  • Peptides
  • Proto-Oncogene Proteins c-mdm2
  • Silver / chemistry

Substances

  • Peptides
  • Silver
  • Gold
  • MDM2 protein, human
  • Proto-Oncogene Proteins c-mdm2